Treatment of bleeding complications in patients on anticoagulant therapy

Siavash Piran1, Sam Schulman1,2

  • 1Department of Medicine, Division of Hematology and Thromboembolism, and Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Canada; and.

Blood
|December 19, 2018
PubMed

Insights

Managing bleeding in patients on anticoagulant therapy requires prompt reversal of anticoagulant effects, especially for severe hemorrhages. Understanding the specific anticoagulant and last dose is crucial for effective treatment, alongside supportive hemostatic measures.

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Emergency Medicine

Background:

  • Anticoagulant therapy is essential for preventing thrombotic events but carries a risk of hemorrhagic complications.
  • Gastrointestinal bleeding is common, while intracranial hemorrhage presents the worst prognosis.

Purpose of the Study:

  • To review the management of hemorrhagic complications in patients receiving anticoagulant therapy.
  • To discuss the crucial role of anticoagulant reversal in life-threatening or massive hemorrhages.

Main Methods:

  • Review of current literature and clinical guidelines on managing anticoagulant-related bleeding.
  • Analysis of different anticoagulant classes: vitamin K antagonists, heparins, fondaparinux, direct thrombin inhibitors, and direct factor Xa inhibitors.
  • Evaluation of the utility of laboratory data and specific antidotes in emergency settings.

Main Results:

  • Standard bleeding management protocols apply, with additional focus on anticoagulant reversal for severe cases.
  • Effective reversal necessitates knowing the specific anticoagulant and last ingestion time.
  • Laboratory data aids reversal for some anticoagulants, but not all, in emergencies.
  • Specific antidotes are emerging, but supportive care with antifibrinolytics or prothrombin complex concentrates remains vital.

Conclusions:

  • Prompt and informed management is key for hemorrhagic complications during anticoagulant therapy.
  • Reversal strategies must be tailored to the specific anticoagulant and clinical scenario.
  • Supportive hemostatic measures are critical when specific antidotes are unavailable or insufficient.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.4K
Bleeding in Fresh Concrete01:22

Bleeding in Fresh Concrete

Bleeding in fresh concrete occurs when water from the mix rises to the surface. This happens because the mix's solid components fail to retain all the water as they settle, leading to separation where water collects at the top. The severity of bleeding can be measured by assessing the total settlement or by noting the decrease in height per unit height of concrete.
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
576
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
815
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
619
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.9K